Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruutu

Showing results (451-460 of 483) with videos related to

Pageof 49
Sort By:
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Blood|April 7, 2006
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromesRodrigo Martino, Simona Iacobelli, Ronald Brand, et al.
Bone Marrow Transplantation|February 21, 2007
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myelomaM Schmidt-Hieber, I W Blau, R Trenschel, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Bone Marrow Transplantation|December 7, 2023
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working PartyLars Klingen Gjærde, Tapani Ruutu, Christophe Peczynski, et al.
Leukemia|September 30, 2005
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)M Aoudjhane, M Labopin, N C Gorin, et al.
The Pediatric Infectious Disease Journal|June 2, 2009
Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trialMarilla G Lucero, Hanna Nohynek, Gail Williams, et al.
Leukemia & Lymphoma|December 1, 1996
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell supportH E Johnsen, B Björkstrand, K Carlson, et al.
Bone Marrow Transplantation|December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningJ Casper, J Holowiecki, R Trenschel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 5, 2015
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMTG W Basak, W Wiktor-Jedrzejczak, M Labopin, et al.
Pageof 49

Showing results (451-460 of 483) with videos related to

Sort By:
Pageof 49
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Blood|April 7, 2006
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromesRodrigo Martino, Simona Iacobelli, Ronald Brand, et al.
Bone Marrow Transplantation|February 21, 2007
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myelomaM Schmidt-Hieber, I W Blau, R Trenschel, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Bone Marrow Transplantation|December 7, 2023
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working PartyLars Klingen Gjærde, Tapani Ruutu, Christophe Peczynski, et al.
Leukemia|September 30, 2005
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)M Aoudjhane, M Labopin, N C Gorin, et al.
The Pediatric Infectious Disease Journal|June 2, 2009
Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trialMarilla G Lucero, Hanna Nohynek, Gail Williams, et al.
Leukemia & Lymphoma|December 1, 1996
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell supportH E Johnsen, B Björkstrand, K Carlson, et al.
Bone Marrow Transplantation|December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningJ Casper, J Holowiecki, R Trenschel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 5, 2015
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMTG W Basak, W Wiktor-Jedrzejczak, M Labopin, et al.
Pageof 49